Processa Pharmaceuticals Inc PCSA shares are trading lower by 23% to $0.21 during Thursday’s session after the company announced it will effect a 1-for-20 reverse stock split.
The 1-for-20 reverse stock split is intended to meet Nasdaq’s minimum bid price requirement. Effective January 22, the common stock will trade on a split-adjusted basis.
This move reduces outstanding shares from 24.6 million to 1.2 million, with proportional adjustments to equity awards and warrants. Fractional shares won’t be issued.
Continental Stock Transfer & Trust will be the exchange agent for the reverse stock split.
See Also: Bitcoin, Ethereum Fall Following Jobless Claims Data
According to data from Benzinga Pro, PCSA has a 52-week high of $1.27 and a 52-week low of $0.18.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
